More than 50 medicines including paracetamol fail the quality test, be careful if you are also taking it

New Delhi: India’s drug regulator has declared 53 drugs including calcium and vitamin D3 supplements, anti-diabetes pills and high blood pressure medicines as failed in quality tests. These include medicines of many reputed companies. The Central Drugs Standards Control Organization (CDSCO) has found more than 50 medicines to be of poor quality. These include calcium and vitamin D3 supplements, diabetes pills and high blood pressure medicines. These medicines were found to be substandard in the random sampling done every month.

These medicines failed the quality test

CDSCO has added the names of 53 medicines in its new Not of Standard Quality (NSQ) alert list. State drug officers do random sampling every month and on that basis NSQ alerts are issued. The medicines that have failed the quality test include many famous medicines like Vitamin C and D3 tablets Shelcal, Vitamin B complex and Vitamin C softgel, antacid Pan-D, paracetamol tablet IP 500 mg, diabetes medicine Glimepiride, high blood pressure medicine Telmisartan. These medicines are manufactured by companies like Hetero Drugs, Alkem Laboratories, Hindustan Antibiotics Limited (HAL), Karnataka Antibiotics & Pharmaceuticals Ltd, Meg Lifesciences, Pure & Cure Healthcare.

From Covid vaccine to TB-dengue… Delhi’s Gokulpuri is ready for every trial, sero survey continues

People who consume paracetamol and pan D should be careful

Metronidazole, a medicine used to treat stomach infection, also failed the quality test. It is manufactured by PSU Hindustan Antibiotic Limited (HAL). High blood pressure medicine Telmisartan also failed the test. Shelcal, distributed by Torrent Pharmaceuticals and manufactured by Uttarakhand-based Pure & Cure Healthcare, also failed the test. Besides this, a Kolkata-based drug-testing lab has declared Alkem Health Science’s antibiotics Clavam 625 and Pan D as fake. The same lab found Hyderabad-based Hetero’s Cepodem XP 50 Dry Suspension, given to children for serious bacterial infections, to be of substandard quality. Paracetamol tablets of Karnataka Antibiotics & Pharmaceuticals Ltd were also declared to have failed the quality test.

Two lists of medicines released which failed in quality test

The Drug Controller of India has released two lists of medicines that failed the quality test. One list contains 48 popular medicines, while the other list contains 5 more medicines along with the responses of the drug companies that failed the test. However, the companies in their responses have refused to take responsibility for the medicines and said that they are fake. In the column of the drug manufacturers’ response, it is written that the actual manufacturer (as per the label claim) has stated that this batch of the product has not been manufactured by them and it is a fake drug. It is being said that the product is fake, however, it is being investigated.

156 medicines were banned

In August, the CDSCO banned over 156 fixed-dose drug combinations from the Indian market, saying they posed risks to people. These drugs included fever, painkillers and allergy pills.